Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — September 2023

Genmab — September 2023

Planlagt Fastgjort Låst Flyttet Genmab
781 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • StockBullS Offline
    StockBullS Offline
    StockBull
    wrote on sidst redigeret af
    #588

    Link Preview Image
    The Trading & Investment Specialist

    Saxo Bank A/S is a fully licensed and regulated Danish bank with an online trading platform that empowers you to invest across global financial markets.

    favicon

    (www.saxotrader.com)

    1 Reply Last reply
    0
    • StockBullS Offline
      StockBullS Offline
      StockBull
      wrote on sidst redigeret af
      #589

      Link Preview Image
      The Trading & Investment Specialist

      Saxo Bank A/S is a fully licensed and regulated Danish bank with an online trading platform that empowers you to invest across global financial markets.

      favicon

      (www.saxotrader.com)

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #590

        Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data https://www.dovepress.com/therapeutic-potential-of-tisotumab-vedotin-in-the-treatment-of-recurre-peer-reviewed-fulltext-article-CMAR

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #591

          Second-Line Tisotumab Vedotin Shows Durability in Cervical Cancer https://www.targetedonc.com/view/second-line-tisotumab-vedotin-shows-durability-in-cervical-cancer

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #592

            20 November 2023 at Panum, UCPH, Keynote speaker Jan G. J. van de Winkel https://bridge.ku.dk/alumni-network/alumni-event/ may be of interest to some locals

            1 Reply Last reply
            0
            • R Offline
              R Offline
              Riis7
              wrote on sidst redigeret af
              #593

              Maxime
              det er os 3 år ikke 2 år;-)

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #594

                SITC 2023 Abstract titles out

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #595

                  SITC 681-
                  innovaTV 207 Parts E and F: A phase 2 study of tisotumab vedotin in patients with head and neck squamous cell carcinoma (trial in progress)

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #596

                    I am not sure if this will be the first data outside of cervical cancer? these are the arms with pembrolizumab and
                    carboplatin. https://classic.clinicaltrials.gov/ct2/show/NCT03485209

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #597

                      SITC Abstract 1181-

                      GEN1042-mIgG2a, an Fc-inert mouse-human chimeric variant of GEN1042 (DuoBody®-CD40x4-1BB), exhibits in vivo antitumor activity and peripheral immune modulation

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #598

                        SITC Abstract 813-

                        Combination of HexaBody-CD27 with PD-(L)1 blockade potentiates single-agent activity leading to enhanced human T-cell effector functions in vitro

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #599

                          that is GEN1053

                          1 Reply Last reply
                          0
                          • A Offline
                            A Offline
                            AaBforever
                            wrote on sidst redigeret af
                            #600

                            Lidt tankevækkende...det har været bedre at have penge i banken....;-)

                            1 Reply Last reply
                            0
                            • J Offline
                              J Offline
                              JKY_VH
                              wrote on sidst redigeret af
                              #601

                              med negativ rente?

                              1 Reply Last reply
                              0
                              • A Offline
                                A Offline
                                AaBforever
                                wrote on sidst redigeret af
                                #602

                                Genmab i år -13% bankbogen +2,75%:-)

                                1 Reply Last reply
                                0
                                • K Offline
                                  K Offline
                                  Klarussen
                                  wrote on sidst redigeret af
                                  #603

                                  Frem og tilbage er lige langt, også igår/idag

                                  1 Reply Last reply
                                  0
                                  • A Offline
                                    A Offline
                                    AaBforever
                                    wrote on sidst redigeret af
                                    #604

                                    Frem og tilbage her i huset er noget HELT andet:-D

                                    1 Reply Last reply
                                    0
                                    • A Offline
                                      A Offline
                                      AaBforever
                                      wrote on sidst redigeret af
                                      #605

                                      Jeg er mere glad for at kigge på min bankbog end på Genmab ihvertfald pt:-)

                                      1 Reply Last reply
                                      0
                                      • R Offline
                                        R Offline
                                        Riis7
                                        wrote on sidst redigeret af
                                        #606

                                        Men der tager kun 2 min , så hurtigt overstået 😉

                                        1 Reply Last reply
                                        0
                                        • R Offline
                                          R Offline
                                          Riis7
                                          wrote on sidst redigeret af
                                          #607

                                          Saxo bank gir 3 procent i rente:-)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper